Genetic Technologies (GENE) annual balance sheet covering fiscal 2017 through 2018, as reported to the SEC. This statement has 1 line item across 2 periods.

• The biggest items reported as of June 30, 2018 are trade and other receivables at $7.11K.

A balance sheet shows what a company owns and what it owes on a single date. The difference between the two belongs to shareholders.